top of page
Scientist with Test Tubes_edited_edited.jpg

EFIL turns LIFE around

Revolutionizing Metabolic and Related Disease Treatments

Our Current Focus

EFIL targets metabolic diseases with innovative ACAT inhibitor treatments where traditional therapies fall short.hort.

EFIL BioScience

 

Suite 602, Bando Ivyvalley, 686 Cheonggyesan-ro, Soojeong-gu, Seongnam, Gyeonggi-do, Republic of Korea 13105 

1330 Avenue of The Americas, STE 23A, New York, NY 10019, United States of America

Email: media@efilbio.com

​

Copyright ⓒ 2021-2025 EFIL BioScience All rights Reserved.

  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
bottom of page